These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11124851)

  • 1. The CYP2E1 knockout delivers another punch: first ASH, now NASH. Alcoholic steatohepatitis. Nonalcoholic steatohepatitis.
    Maher J
    Hepatology; 2001 Jan; 33(1):311-2. PubMed ID: 11124851
    [No Abstract]   [Full Text] [Related]  

  • 2. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.
    Leclercq IA; Farrell GC; Field J; Bell DR; Gonzalez FJ; Robertson GR
    J Clin Invest; 2000 Apr; 105(8):1067-75. PubMed ID: 10772651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis of non-alcoholic fatty liver].
    Pirlich M; Lochs H; Schmidt HH
    Z Gastroenterol; 2001 May; 39(5):441-2. PubMed ID: 11413919
    [No Abstract]   [Full Text] [Related]  

  • 4. P-450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes.
    Amet Y; Lucas D; Zhang-Gouillon ZQ; French SW
    Alcohol Clin Exp Res; 1998 Apr; 22(2):455-62. PubMed ID: 9581653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
    Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
    Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women.
    Varela NM; Quiñones LA; Orellana M; Poniachik J; Csendes A; Smok G; Rodrigo R; Cáceres DD; Videla LA
    Biol Res; 2008; 41(1):81-92. PubMed ID: 18769766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of lipid peroxidation in non-alcoholic steatohepatitis].
    Fraenkel E; Lazúrová I; Fehér J
    Orv Hetil; 2004 Mar; 145(12):611-8. PubMed ID: 15119115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice.
    Lu Y; Zhuge J; Wang X; Bai J; Cederbaum AI
    Hepatology; 2008 May; 47(5):1483-94. PubMed ID: 18393316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
    Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
    Kamada Y; Matsumoto H; Tamura S; Fukushima J; Kiso S; Fukui K; Igura T; Maeda N; Kihara S; Funahashi T; Matsuzawa Y; Shimomura I; Hayashi N
    J Hepatol; 2007 Oct; 47(4):556-64. PubMed ID: 17459514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative roles of CYP2E1 and CYP1A2 in mouse uroporphyria caused by acetone.
    Sinclair PR; Gorman N; Walton HS; Bement WJ; Szakacs J; Gonzalez FJ; Dalton TP; Nebert DW; Sinclair JF
    Arch Biochem Biophys; 2000 Dec; 384(2):383-90. PubMed ID: 11368328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-alcoholic steatohepatitis].
    Duvnjak M; Virović L
    Acta Med Croatica; 2003; 57(3):189-99. PubMed ID: 14582465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
    Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR
    Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nonalcoholic steatohepatitis. Three case reports].
    Eivindson MV; Hamilton-Dutoit S; Grønbaek H
    Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nonalcoholic steatohepatitis (NASH)].
    Ishii H; Okuyama K
    Ryoikibetsu Shokogun Shirizu; 1995; (8):28-31. PubMed ID: 8581628
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical characteristics for optimizing CYP2E1 inhibition.
    van de Wier B; Balk JM; Bast A; Koek GH; Haenen GR
    Chem Biol Interact; 2015 Dec; 242():139-44. PubMed ID: 26428356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease of obesity.
    Sachdev MS; Riely CA; Madan AK
    Obes Surg; 2006 Nov; 16(11):1412-9. PubMed ID: 17132404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat paradox of steatohepatitis.
    Tsukamoto H; She H; Hazra S; Cheng J; Wang J
    J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S104-7. PubMed ID: 18336651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.